平行移植物腔内修复治疗复杂腹主动脉瘤的单中心中期结果
该单中心回顾性研究纳入35例症状性复杂腹主动脉瘤高危患者,均接受平行移植物腔内动脉瘤修复(pg-EVAR),36个月时烟囱移植物一期通畅率88%、总生存率71%、免于再干预率78%,提示pg-EVAR对复杂解剖且开放手术高风险患者安全有效。
要点
- 35例症状性复杂AAA高危患者接受pg-EVAR,36个月烟囱移植物一期通畅率88%。
- 36个月总生存率71%,免于所有再干预率78%。
- pg-EVAR对复杂解剖且开放手术高风险患者安全有效。
核心结论
- pg-EVAR对于复杂解剖且开放手术风险差的腹主动脉瘤患者似乎是安全有效的治疗方式。
主要发现
- 35例患者共置入55枚烟囱移植物,其中47枚置于肾动脉、8枚置于肠系膜上动脉。
- 所有病例主体支架均使用Endurant支架。
- 36个月时烟囱移植物一期通畅率为88%,患者总生存率为71%,免于所有再干预率为78%。
临床怎么用
- 对于复杂解剖且开放手术高风险的腹主动脉瘤患者,可考虑采用pg-EVAR作为治疗选择。
局限性
- 本研究为单中心回顾性分析,样本量较小(35例),结论需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We sought to evaluate the midterm results of parallel-graft-endovascular aneurysm repair (pg-EVAR) for complex aortic anatomy in high-risk candidates for open surgical repair of abdominal aortic aneurism (AAA). METHODS: Clinical and radiographic information on 35 patients treated by pg-EVAR between March 2010 and December 2015 was retrospectively reviewed and analyzed. All patients presented with symptomatic aneurysms and were treated within 3 days of clinical presentation. Primary end points included primary chimney graft patency, overall survival, and freedom from all reintervention. RESULTS: Overall, 55 chimney grafts were placed into 47 renal arteries and 8 superior mesenteric arteries in 35 patients. An endurant stent graft was used as the main body component in all cases. At 36 months, primary chimney graft patency was 88%, overall survival of patients was 71%, and the rate of freedom from all reintervention was 78%. CONCLUSIONS: Considering our midterm results, pg-EVAR seems to be a safe and effective treatment for patients with complex anatomies and at poor risk for open repair.
引用
- Adovasio R, Chiarandini S, Calvagna C, et al. Treatment of Complex Abdominal Aortic Aneurysms with Parallel Graft-Endovascular Aneurysm Repair. Retrospective Analysis of a Single Center Experience and Midterm Results. Ann Vasc Surg. 2017. PMID: 28943486. doi:10.1016/j.avsg.2017.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。